Breaking News Instant updates and real-time market news.

IBM

IBM

$124.77

-1.67 (-1.32%)

, RHT

Red Hat

$116.66

-3.85 (-3.19%)

14:54
10/28/18
10/28
14:54
10/28/18
14:54

IBM to acquire Red Hat for $190 per share

IBM (IBM) and Red Hat (RHT) announced that the companies have reached a definitive agreement under which IBM will acquire all of the issued and outstanding common shares of Red Hat for $190 per share in cash, representing a total enterprise value of approximately $34B. With this acquisition, IBM will remain committed to Red Hat's open governance, open source contributions, participation in the open source community and development model, and fostering its widespread developer ecosystem. In addition, IBM and Red Hat will remain committed to the continued freedom of open source, via such efforts as Patent Promise, GPL Cooperation Commitment, the Open Invention Network and the LOT Network. IBM and Red Hat also will continue to build and enhance Red Hat partnerships, including those with major cloud providers, such as Amazon Web Services (AMZN), Microsoft (MSFT) Azure, Google (GOOG; GOOGL) Cloud, Alibaba (BABA) and more, in addition to the IBM Cloud. At the same time, Red Hat will benefit from IBM's hybrid cloud and enterprise IT scale in helping expand their open source technology portfolio to businesses globally. Upon closing of the acquisition, Red Hat will join IBM's Hybrid Cloud team as a distinct unit, preserving the independence and neutrality of Red Hat's open source development heritage and commitment, current product portfolio and go-to-market strategy, and unique development culture. Red Hat will continue to be led by Jim Whitehurst and Red Hat's current management team. Jim Whitehurst also will join IBM's senior management team and report to Ginni Rometty. IBM intends to maintain Red Hat's headquarters, facilities, brands and practices. The acquisition will accelerate IBM's revenue growth, gross margin and free cash flow within 12 months of closing. It also will support a solid and growing dividend. The company will continue with a disciplined financial policy and is committed to maintaining strong investment grade credit ratings. The company will target a leverage profile consistent with a mid to high single A credit rating. The company intends to suspend its share repurchase program in 2020 and 2021. The company intends to close the transaction through a combination of cash and debt. The acquisition has been approved by the boards of directors of both IBM and Red Hat. It is subject to Red Hat shareholder approval. It also is subject to regulatory approvals and other customary closing conditions. It is expected to close in the latter half of 2019.

IBM

IBM

$124.77

-1.67 (-1.32%)

RHT

Red Hat

$116.66

-3.85 (-3.19%)

AMZN

Amazon.com

$1,638.80

-141.2 (-7.93%)

MSFT

Microsoft

$106.99

-1.5 (-1.38%)

GOOG

Alphabet

$1,071.02

-27.61 (-2.51%)

GOOGL

Alphabet Class A

$1,080.67

-25.33 (-2.29%)

BABA

Alibaba

$142.94

-1.65 (-1.14%)

  • 28

    Oct

  • 28

    Oct

  • 30

    Oct

  • 02

    Nov

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

IBM IBM
$124.77

-1.67 (-1.32%)

10/18/18
10/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. IBM (IBM) downgraded to Hold from Buy at Argus with analyst James Kelleher saying the company's growth prospects are "fading." 2. Gap (GPS) downgraded to Underweight from Neutral at JPMorgan with analyst Matthew Boss saying the timeframe for sequential same-store-sales improvement at the Gap brand and a return to the "momentum" last seen in the second half of 2017 is now less certain as the brand grapples with operational issues and an "assortment imbalance." 3. Yum! Brands (YUM) downgraded to In Line from Outperform at Evercore ISI with analyst Matt McGinley saying the recent move in shares have placed its valuation closer to the top of its peer franchised peers. 4. EnLink Midstream Partners (ENLK) downgraded to Neutral from Buy at Citi with analyst Mirek Zak citing valuation. 5. Wingstop (WING) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst John Glass citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/18
BNCH
10/26/18
NO CHANGE
Target $100
BNCH
Buy
Mellanox a 'prized' target for 'host of buyers,' says Benchmark
After CNBC reported that Mellanox (MLNX) has hired an advisor to explore strategic alternatives, including a possible sale, Benchmark analyst Gary Mobley said it is difficult to verify the story but he believes the company would "represent a prized M&A target for a host of buyers," including potentially Nvidia (NVDA), Intel (INTC), Broadcom (AVGO), Marvell (MRVL) and "even" IBM (IBM). The analyst, who added that Mellanox's "initial apathy" toward prior M&A talks with Marvell was part of the reason Starboard got involved, keeps a Buy rating on Mellanox shares with a $100 price target.
10/18/18
WEDB
10/18/18
NO CHANGE
Target $165
WEDB
Neutral
IBM price target lowered to $165 from $185 at Wedbush
Wedbush analyst Moshe Katri lowered his price target for IBM to $165 from $185 after the company reported mixed Q3/CY18 results as the "growth" areas at IBM, namely Strategic Imperatives, Cognitive and Cloud are yet to show growth consistency/acceleration while profitability performance also remains unconvincing. The analyst continues to believe that only undertaking the difficult path of aggressively terminating/restructuring underperforming units, hence, sacrificing top-line growth for generating margin/free cash flow improvements will likely generate significant return to shareholders. Katri reiterates a Neutral rating on the shares.
10/18/18
ARGS
10/18/18
DOWNGRADE
ARGS
Hold
IBM downgraded to Hold at Argus on 'fading growth prospects'
As noted earlier, Argus analyst James Kelleher downgraded IBM to Hold after its Q3 revenue miss, saying the company's growth prospects are "fading". The analyst notes that revenues have "flipped back to negative" while margin in key business segments have shrunk. Kelleher adds that even though the stock is trading at a discount, a Hold rating is "appropriate" until the company can show "consistent top-line growth, margin expansion, and earnings acceleration".
RHT Red Hat
$116.66

-3.85 (-3.19%)

09/20/18
BMOC
09/20/18
NO CHANGE
Target $158
BMOC
Market Perform
Red Hat price target lowered to $158 from $177 at BMO Capital
BMO Capital analyst Keith Bachman lowered his price target on Red Hat to $158 and kept his Market Perform rating after its Q2 earnings miss, adding that the "solid" operating margins and "good" free cash flow in the quarter will likely be overshadowed by the worse than expected infrastructure growth rate of 8%. Despite the management's confidence in expected improved growth coming from a stronger renewal base, the analyst says his neutral stance is justified by the timing and uncertainty surrounding those expectations. Longer term, Bachman is still positive on the opportunity for Red Hat to be a "strong participant in building the hybrid cloud".
10/17/18
BARD
10/17/18
INITIATION
BARD
Neutral
Red Hat assumed with a Neutral at Baird
Baird analyst Jonathan Ruykhaver assumed coverage on Red Hat with a Neutral rating and $135 price target. The analyst believes the challenge facing Red Hat is that "paid RHEL growth could be slowing as more digital initiatives and new workloads whether on-premise or in the public cloud run increasingly on free Linux."
10/23/18
NEED
10/23/18
INITIATION
NEED
Buy
Red Hat, Pivotal Software, ServiceNow initiated with a Buy at Needham
As reported earlier, Needham analyst Jack Andrews initiated Red Hat (RHT), Pivotal Software (PVTL), and ServiceNow (NOW) with Buy ratings as part of his broader research note on select cloud-driven infrastructure software companies. The analyst notes that he expects new proprietary applications to generate rapid growth of cloud-based workloads, making the "platform as a service", or PaaS, market "one of the fastest growing segments in the technology stack". Andrews also points out that in addition to allowing "enterprises to run machine learning and deep learning algorithms in order to glean insights on how to improve customer experiences", a unique characteristic of infrastructure software companies is their pricing model driven by "per compute" or "consumption basis". The analyst contends that this makes them an attractive investment as "an infrastructure software vendor can maintain a long tail of growth within an enterprise by continuing to add licenses". Andrews assigns Red Hat a price target of $183, Pivotal Software a target of $25, and ServiceNow a price target of $224.
10/22/18
NEED
10/22/18
INITIATION
NEED
Buy
Red Hat initiated with a Buy at Needham
Needham analyst Jack Andrews initiated Red Hat with a Buy and $183 price target.
AMZN Amazon.com
$1,638.80

-141.2 (-7.93%)

10/26/18
JEFF
10/26/18
NO CHANGE
Target $2300
JEFF
Buy
Jefferies remains bullish on Amazon shares after 'strong' Q3
Jefferies analyst Brent Thill says he remains bullish on shares of Amazon.com following last night's "strong" Q3 results. He raised his price target to $2,300 from $2,260 and reiterates a Buy rating on the stock. While revenue came in just shy of consensus, operating income was $1.6B ahead of estimates and 6.6% operating margin was the highest in 14 years, Thill tells investors in a post-earnings research note titled "Every Rockstar Needs a Break." While the Q4 guidance disappointed with 15% revenue growth at the midpoint, deceleration was expected as Amazon lapped the Whole Foods acquisition, says the analyst.
10/26/18
BARD
10/26/18
NO CHANGE
Target $2100
BARD
Outperform
Amazon mixed guidance obscures underlying strengths, says Baird
Baird analyst Colin Sebastian said the top-line miss and mixed guidance from Amazon obscured the company's underlying strengths. He said the higher-margin segments of the business remain healthy and drove the current quarter's margin upside. He said with its soft Q4 guidance, holiday execution will be scrutinized more closely, but he believes they will come in at the high-end of guidance. Sebastian said any pullback would be a buying opportunity and he reiterated his Outperform rating and $2,100 price target on Amazon.com shares.
10/26/18
MSCO
10/26/18
NO CHANGE
Target $2400
MSCO
Overweight
Morgan Stanley remains bullish on Amazon, trims price target to $2,400
Morgan Stanley analyst Brian Nowak said he remains bullish on Amazon following its Q3 results, though he reduced his price target on the stock to $2,400 from $2,500 after its revenue missed expectations. He noted that GAAP EBIT margins are expanding at "record rates" even as the company continues to invest to penetrate the next $3.7T of addressable spending in new potential markets. Bears will likely pick at the deceleration of Amazon's revenue ex- Whole Foods, but Nowak views this as largely a timing issue, he added. While he keeps an Overweight rating on Amazon, Nowak acknowledges it is likely to take a strong Q4 top-line and evidence of continued profitability into 2019 to materially drive outperformance for the shares.
10/26/18
RHCO
10/26/18
NO CHANGE
Target $2250
RHCO
Buy
Amazon.com price target raised to $2,250 from $2,150 at SunTrust
SunTrust analyst Youssef Squali raised his price target on Amazon to $2,250 and kept his Buy rating after its Q3 results showing a "solid top line and impressive out-performance" in operational efficiency and profitability. The analyst believes that the company's Q4 revenue guide is on a "conservative side" going into his expectations of a "robust holiday season". Squali further cites Amazon's record over 100M Prime manageable items being available for a free 2-day shipping along with the company's Q4 tailwinds in India.
MSFT Microsoft
$106.99

-1.5 (-1.38%)

10/25/18
FBCO
10/25/18
NO CHANGE
Target $125
FBCO
Outperform
Microsoft to benefit from hybrid cloud migration, says Credit Suisse
Credit Suisse analyst Brad Zelnick argues that strong Q1 results reinforce his thesis that Microsoft will be a primary beneficiary of a migration to hybrid cloud environments and is uniquely positioned versus other hyper scale competitors given its hybrid architectural advantage. The analyst notes that the quarter overall was strong despite Azure revenue slightly below his estimates and Q2 was largely guided ahead of Street when adjusting for GitHub. Zelnick reiterates an Outperform rating and $125 price target on the shares.
10/25/18
MSCO
10/25/18
NO CHANGE
Target $130
MSCO
Overweight
Microsoft shares should 'grind higher' amid solid execution, says Morgan Stanley
Morgan Stanley analyst Keith Weiss said Microsoft is seeing the hybrid cloud benefits and notes that its improved secular positioning and solid execution have now lead to seven straight quarters of accelerating revenue growth. The analyst, who raised his FY19 EPS estimates by 4% following the company's Q1 earnings report, believes the shares "should grind higher" toward his $130 price target. Weiss maintains an Overweight rating on Microsoft.
10/25/18
WEDB
10/25/18
NO CHANGE
Target $140
WEDB
Outperform
Microsoft momentum continues after another cloud beat, says Wedbush
Wedbush analyst Daniel Ives notes Microsoft (MSFT) delivered another "robust" quarter. The company exceeded expectations on nearly every metric across the board with no soft spots. Redmond is still in the early innings of benefiting from a transformational secular cloud shift in this two-horse race with Amazon (AMZN) as more enterprises around the world head down the cloud path. Ives is bullish on Microsoft into 2019 given his thesis on Azure's cloud momentum is still in its early days of playing out with the company's massive installed base, Office 365 transition on consumer/enterprise providing growth tailwinds for the next 12-18 months at least, and newer integrated product initiatives around consumers and cloud services are still playing out within Redmond's ubiquitous installed base of consumers and enterprises worldwide. He reiterates an Outperform rating and $140 price target on Microsoft shares.
10/25/18
KEYB
10/25/18
NO CHANGE
Target $125
KEYB
Overweight
Cloud/Internet reshaping Microsoft growth, profit trajectory, says KeyBanc
KeyBanc analyst Brent Bracelin reiterates an Overweight rating on Microsoft shares, while raising his price target on the stock to $125 from $123 on a multiyear model transformation driven by fast-growing cloud and internet segments that he estimates could top $70B in revenue by CY20 versus $18.5B in CY16. Further, the analyst points out that the $1.2B revenue beat for Q1 was "impressive," marking the seventh consecutive increase in total revenue growth to 18.5% year over year driven by internet, cloud, server tools, and gaming momentum.
GOOG Alphabet
$1,071.02

-27.61 (-2.51%)

10/26/18
UBSW
10/26/18
NO CHANGE
Target $1400
UBSW
Buy
Alphabet results enforce industry leadership, says UBS
UBS analyst Eric Sheridan said Alphabet's Q3 results of over 20% forex-neutral Sites revenue growth, moderating Sites TAC and core Google margins were better than feared and should be the main takeaways from their Q3 report. The analyst said any price pressure on the back of these results misses the big picture. Sheridan reiterated his Buy rating and $1,400 price target on Alphabet shares.
10/26/18
MSCO
10/26/18
NO CHANGE
Target $1500
MSCO
Overweight
Alphabet steadily monetizing across all 'ages' of business, says Morgan Stanley
Morgan Stanley analyst Brian Nowak said in a post-earnings research note that Alphabet (GOOGL) is steadily monetizing and investing in its oldest, middle-age and youngest businesses. He noted that its oldest market, the U.S., is still growing 20% year-over-year and its oldest product, namely desktop search, is still growing about 7% year-over-year. Meanwhile, its innovation and investments are driving strong growth in "middle-aged" products, such as mobile search and YouTube, and the longer-term investments, like Waymo, are beginning to show "green shoots." He keeps an Overweight rating on Alphabet shares, but trimmed his price target to $1,500 from $1,515 to account for a lower adjusted EBITDA view in FY19 and FY20 due to slightly lower revenue and higher assumed investments.
10/26/18
KEYB
10/26/18
NO CHANGE
Target $1430
KEYB
Overweight
Alphabet 'undervalued,' as KeyBanc recommends buying shares
KeyBanc analyst Andy Hargreaves maintained an Overweight rating and $1,430 price target on Alphabet following the company's quarterly results. In a research note to investors, the analyst says Google has grown ad revenue by 15% or more in 33 out of the last 36 quarters, and retains excellent potential to sustain this through Search, Maps, and YouTube, as well as large opportunities in hardware, cloud, Other Bets, and private investments. At ~12.3x 2019 EV/Google EBITDA, he views Alphabet as undervalued and recommend buying the shares.
10/26/18
JPMS
10/26/18
NO CHANGE
Target $1350
JPMS
Overweight
Alphabet price target lowered to $1,350 from $1,440 at JPMorgan
JPMorgan analyst Doug Anmuth lowered his price target for Alphabet to $1,350 following last night's Q3 results and keeps an Overweight rating on the shares. Revenue came in a little light, but overall results continue to show that the company's investments in the business are driving 20%-plus growth, Anmuth tells investors in a post-earnings research note. Net/net, 22% revenue growth is good, but it was Alphabet's slowest growth in three years, adds the analyst. However, he believes Alphabet continues to execute well and notes that his new target still represents 27% upside to after-market levels.
GOOGL Alphabet Class A
$1,080.67

-25.33 (-2.29%)

10/26/18
GSCO
10/26/18
NO CHANGE
Target $1300
GSCO
Conviction Buy
Alphabet price target lowered to $1,300 from $1,500 at Goldman Sachs
Goldman Sachs analyst Heather Bellini lowered Alphabet's price target to $1,300 from $1,500 citing multiple compression across the group following the "rare revenue miss" driven by FX. Bellini reiterated her Conviction Buy rating on Alphabet saying shares trade at 18x her CY20 estimate of $58.80, versus $62.22 prior.
BABA Alibaba
$142.94

-1.65 (-1.14%)

10/22/18
BNCH
10/22/18
NO CHANGE
Target $220
BNCH
Buy
Alibaba price target lowered to $220 from $245 at Benchmark
Benchmark analyst Fawne Jiang expects Alibaba to continue to outperform the e-commerce industry due to healthy gross merchandise volume growth in its core business, but she believes earnings growth could come under pressure in the near-term given stepped up investments in New Retail initiatives and uncertainties from Taobao's new upgrade. After lowering her earnings estimates, Jiang cut her price target on Alibaba shares to $220 ahead of its Q2 earnings report on November 2 before the market opens. However, she maintains a Buy rating on Alibaba.
10/12/18
STFL
10/12/18
NO CHANGE
Target $200
STFL
Buy
Stifel replaces Alibaba with Amazon on Select List after target drop
Stifel analyst Scott Devitt removed Alibaba (BABA) from his firm's Select List and replaced it with Amazon.com (AMZN). The analyst cites an "increasingly uncertain" China macro environment and near-term optimism for Amazon for the change. He also updated his Alibaba model, which resulted in near-term revenue growth assumptions that are 300 basis points lower versus his prior forecast. However, despite the difficult China market backdrop, Devitt continues to view Alibaba as a core long-term holding. He lowered his price target for the shares to $200 from $220 while keeping a Buy rating on the name.
10/12/18
UBSW
10/12/18
NO CHANGE
Target $220
UBSW
Buy
Alibaba price target lowered to $220 from $230 at UBS
UBS analyst Jerry Liu lowered his price target on Alibaba to $220 from $230 and he lowered his estimates as well. The analyst revisions come as he factors in more macro weakness, but he believes the company remains well positioned against competitors and said it remains his top pick. Liu reiterated his Buy rating on Alibaba shares.
10/18/18
OPCO
10/18/18
NO CHANGE
Target $210
OPCO
Outperform
Alibaba price target lowered to $210 from $230 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for Alibaba to $210 from $230 as he now expects softer core commerce revenue, mainly due to modestly slower e-commerce industry trends and mix to non-paid product recommendations. In addition, the analyst also expects investments at New Retail, Ele.me and DME to have a greater impact on near-term margins. Helfstein reiterates an Outperform rating on the shares as he expects trade war rhetoric to subside after mid-term elections.

TODAY'S FREE FLY STORIES

TCEHY

Tencent

$0.00

(0.00%)

12:59
01/19/19
01/19
12:59
01/19/19
12:59
Periodicals
Tencent not the best opportunity out there right now, Barron's says »

After securing a billion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

12:53
01/19/19
01/19
12:53
01/19/19
12:53
Periodicals
Bae Systems will mount new charge, Barron's says »

Bae Systems has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

, COST

Costco

$213.59

2.15 (1.02%)

12:50
01/19/19
01/19
12:50
01/19/19
12:50
Periodicals
Costco might be 'good buy' following 2018 pullback, Barron's says »

Part of what makes Costco…

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

COST

Costco

$213.59

2.15 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 31

    Jan

  • 20

    Feb

  • 03

    Mar

VNO

Vornado

$66.40

1.04 (1.59%)

, KRC

Kilroy Realty

$68.23

0.21 (0.31%)

12:45
01/19/19
01/19
12:45
01/19/19
12:45
Periodicals
Kilroy, Vornado Realty have 'solid' prospects, Barron's says »

Office REITs have been…

VNO

Vornado

$66.40

1.04 (1.59%)

KRC

Kilroy Realty

$68.23

0.21 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

GOLD

Barrick Gold

$11.78

-0.11 (-0.93%)

, GG

Goldcorp

$10.37

0.04 (0.39%)

12:41
01/19/19
01/19
12:41
01/19/19
12:41
Periodicals
Gold mining stocks 'an unalloyed bargain,' Barron's says »

Two multibillion-dollar…

GOLD

Barrick Gold

$11.78

-0.11 (-0.93%)

GG

Goldcorp

$10.37

0.04 (0.39%)

NEM

Newmont Mining

$31.77

0.15 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TECH

Bio-Techne

$163.24

1.16 (0.72%)

, A

Agilent

$71.93

1.16 (1.64%)

12:29
01/19/19
01/19
12:29
01/19/19
12:29
Periodicals
Rising demand benefiting Illumina, Thermo Fisher, Barron's says »

Healthy funding and…

TECH

Bio-Techne

$163.24

1.16 (0.72%)

A

Agilent

$71.93

1.16 (1.64%)

DHR

Danaher

$107.43

1.88 (1.78%)

TMO

Thermo Fisher

$240.72

2.55 (1.07%)

ILMN

Illumina

$312.66

2.53 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 05

    Feb

ATVI

Activision Blizzard

$48.64

1.26 (2.66%)

, EA

Electronic Arts

$92.50

3.19 (3.57%)

12:22
01/19/19
01/19
12:22
01/19/19
12:22
Periodicals
EA, Activision struggling to survive a Fortnite World, Barron's says »

Netflix (NFLX) delivered…

ATVI

Activision Blizzard

$48.64

1.26 (2.66%)

EA

Electronic Arts

$92.50

3.19 (3.57%)

NFLX

Netflix

$339.20

-14.02 (-3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 12

    Feb

  • 25

    Feb

AIMT

Aimmune

$22.90

0.26 (1.15%)

, CELG

Celgene

$86.27

-0.32 (-0.37%)

09:01
01/19/19
01/19
09:01
01/19/19
09:01
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AIMT

Aimmune

$22.90

0.26 (1.15%)

CELG

Celgene

$86.27

-0.32 (-0.37%)

BIIB

Biogen

$337.46

-0.93 (-0.27%)

CMRE

Costamare

$4.97

0.09 (1.84%)

DAC

Danaos

$0.90

0.05 (5.88%)

DCIX

Diana Containerships

$0.90

-0.02 (-2.17%)

TGH

Textainer

$13.34

0.57 (4.46%)

NM

Navios Maritime

$2.73

-0.04 (-1.44%)

YRCM

Rogers Cantel

$0.00

(0.00%)

EXPD

Expeditors

$69.34

1.43 (2.11%)

LEN

Lennar

$44.11

-0.64 (-1.43%)

KBH

KB Home

$20.30

-0.28 (-1.36%)

PHM

PulteGroup

$26.58

-0.27 (-1.01%)

Z

Zillow

$33.93

0.35 (1.04%)

ZG

Zillow

$33.74

0.35 (1.05%)

RLGY

Realogy

$18.27

-0.155 (-0.84%)

RDFN

Redfin

$18.49

0.48 (2.67%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.78

0.16 (0.96%)

F

Ford

$8.59

0.23 (2.75%)

GM

General Motors

$38.63

0.35 (0.91%)

HMC

Honda

$29.77

0.22 (0.74%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$125.40

0.505 (0.40%)

VLKAY

Volkswagen

$0.00

(0.00%)

VC

Visteon

$76.43

4.85 (6.78%)

ADNT

Adient

$19.78

1.59 (8.74%)

AXL

American Axle

$14.62

0.45 (3.18%)

DLPH

Delphi Technologies

$15.94

0.44 (2.84%)

APTV

Aptiv

$72.91

1.77 (2.49%)

BWA

BorgWarner

$40.60

0.54 (1.35%)

LEA

Lear

$151.67

0.98 (0.65%)

TEN

Tenneco

$34.61

1.125 (3.36%)

MGA

Magna

$50.91

0.78 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 06

    Feb

  • 07

    Feb

  • 14

    Feb

  • 19

    Feb

  • 25

    Apr

  • 18

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

, FPRX

Five Prime

$11.20

0.53 (4.97%)

04:55
01/19/19
01/19
04:55
01/19/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

ASCO GI 2019 Symposium…

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

FPRX

Five Prime

$11.20

0.53 (4.97%)

KURA

Kura Oncology

$15.70

-0.06 (-0.38%)

ZLAB

Zai Lab

$25.98

-0.05 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/19/19
01/19
04:55
01/19/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

17th Annual dbAccess…

TCCO

Technical Comm Corp

$2.61

-0.19 (-6.79%)

18:02
01/18/19
01/18
18:02
01/18/19
18:02
Hot Stocks
Technical Comm Corp reports notice of failure to satisfy Nasdaq rule »

Technical Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.19

0.455 (7.93%)

17:38
01/18/19
01/18
17:38
01/18/19
17:38
Periodicals
Snap exec fired due to undisclosed relationship with consultant, Cheddar says »

Snap's global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 03

    Mar

SSW

Seaspan

$9.16

0.16 (1.78%)

17:33
01/18/19
01/18
17:33
01/18/19
17:33
Syndicate
Breaking Syndicate news story on Seaspan »

Seaspan files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$49.38

0.75 (1.54%)

17:30
01/18/19
01/18
17:30
01/18/19
17:30
Hot Stocks
Textron subsidiary awarded $439.56M government contract modification »

Bell Helicopter Textron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

TAC

TransAlta

$4.91

0.04 (0.82%)

17:28
01/18/19
01/18
17:28
01/18/19
17:28
Hot Stocks
Mangrove Partners reports 9.4% passive stake in TransAlta »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDS

Telephone and Data

$36.27

0.42 (1.17%)

17:27
01/18/19
01/18
17:27
01/18/19
17:27
Hot Stocks
Telephone and Data's Meyers sells 80,465 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$137.24

2.59 (1.92%)

17:03
01/18/19
01/18
17:03
01/18/19
17:03
Syndicate
Breaking Syndicate news story on GW Pharmaceuticals »

GW Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCSC

Fibrocell Science

$2.03

0.03 (1.50%)

16:55
01/18/19
01/18
16:55
01/18/19
16:55
Syndicate
Breaking Syndicate news story on Fibrocell Science »

Fibrocell Science files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

, ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

16:49
01/18/19
01/18
16:49
01/18/19
16:49
Conference/Events
EnLink Midstream Partners to hold a special shareholder meeting »

Special Shareholder…

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

FDX

FedEx

$176.97

3.72 (2.15%)

16:49
01/18/19
01/18
16:49
01/18/19
16:49
Hot Stocks
FedEx establishes voluntary buyout program for U.S. workers »

FedEx said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

  • 03

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

, ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

16:48
01/18/19
01/18
16:48
01/18/19
16:48
Conference/Events
EnLink Midstream Companies to hold a special shareholder meeting »

Special Shareholder…

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

MKL

Markel

$1,067.03

13.52 (1.28%)

16:36
01/18/19
01/18
16:36
01/18/19
16:36
Hot Stocks
Markel says Anthony Belisle, Alissa Fredricks no longer with company »

Markel Corporation said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NILSY

Norilsk Nickel

$0.00

(0.00%)

16:35
01/18/19
01/18
16:35
01/18/19
16:35
Downgrade
Norilsk Nickel rating change at Goldman Sachs »

Norilsk Nickel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$130.65

1.54 (1.19%)

, ABBV

AbbVie

$89.51

2.28 (2.61%)

16:33
01/18/19
01/18
16:33
01/18/19
16:33
Hot Stocks
AbbVie: Phase 3 study of ibrutinib did not meet primary endpoint »

AbbVie (ABBV) announced…

JNJ

Johnson & Johnson

$130.65

1.54 (1.19%)

ABBV

AbbVie

$89.51

2.28 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 27

    Jan

  • 28

    Jan

  • 18

    Feb

  • 18

    May

FOMX

Foamix

$3.70

-0.14 (-3.65%)

16:32
01/18/19
01/18
16:32
01/18/19
16:32
Conference/Events
Foamix to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.